CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −703 | $4.38 | $3K | 537,557 |
| 2024-05-16 | Alland Leila Director | Purchase | +11,000 | $4.71 | $52K | 82,857 |
| 2024-05-07 | Adage Capital Management, L.P. 10% owner | Purchase · Pre-funded Warrant (right to buy) | +2,948,475 | $4.07 | $12.0M | 2,948,475 |
| 2024-04-26 | Charles Faith L. Director | Purchase | +7,550 | $3.28 | $25K | 78,323 |
| 2024-04-25 | Seshadri Vishwas Chief Executive Officer | Purchase | +10,000 | $3.20 | $32K | 538,260 |
| 2024-04-25 | O'Malley Brendan M. SVP, General Counsel | Purchase | +8,600 | $3.24 | $28K | 188,718 |
| 2024-04-25 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +5,608 | $3.14 | $18K | 233,868 |
| 2024-03-31 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −92 | $7.25 | $667 | 180,026 |
| 2024-03-15 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −703 | $8.14 | $6K | 228,260 |
| 2024-03-04 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −183 | $7.81 | $1K | 180,118 |
| 2024-02-06 | Seshadri Vishwas Chief Executive Officer | Purchase | +20,000 | $4.39 | $88K | 528,260 |
| 2024-01-17 | Alvino Mark Director | Sale | −7,084 | $5.11 | $36K | 62,816 |
| 2023-10-16 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −181 | $4.14 | $749 | 508,260 |
| 2023-09-29 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −13,290 | $3.93 | $52K | 508,441 |
| 2023-09-29 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −6,230 | $3.93 | $24K | 228,963 |
| 2023-09-29 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −6,557 | $3.93 | $26K | 180,301 |
| 2023-09-27 | Silverstein Christine Berni Director | Sale | −6,330 | $3.91 | $25K | 87,884 |
| 2023-09-27 | Charles Faith L. Director | Sale | −8,330 | $4.91 | $41K | 70,773 |
| 2023-09-27 | Alvino Mark Director | Sale | −6,316 | $3.91 | $25K | 69,900 |
| 2023-09-27 | Amoroso Michael Director | Sale | −5,508 | $3.91 | $22K | 108,957 |
Page 7 of 12 · 223 trades